Advanced search
Publication Cover
Cancer Investigation Volume 30, 2012 - Issue 2
Submit an article Journal homepage
238
Views
21
CrossRef citations to date
0
Altmetric
CELLULAR AND MOLECULAR BIOLOGY

Loperamide, an FDA-Approved Antidiarrhea Drug, Effectively Reverses the Resistance of Multidrug Resistant MCF-7/MDR1 Human Breast Cancer Cells to Doxorubicin-Induced Cytotoxicity

Yanfei ZhouDepartments of Oral Pathology, Radiation Oncology, Radiology, Howard University, Washington, DC, USA, Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USACorrespondence[email protected]
,
Rajagopalan SridharDepartments of Oral Pathology, Radiation Oncology, Radiology, Howard University, Washington, DC, USA, Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
,
Liang ShanDepartments of Oral Pathology, Radiation Oncology, Radiology, Howard University, Washington, DC, USA, Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
,
Wei ShaDepartments of Oral Pathology, Radiation Oncology, Radiology, Howard University, Washington, DC, USA, Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
,
Xinbin GuDepartments of Oral Pathology, Radiation Oncology, Radiology, Howard University, Washington, DC, USA, Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
&
Saraswati SukumarDepartments of Oral Pathology, Radiation Oncology, Radiology, Howard University, Washington, DC, USA, Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Pages 119-125 | Published online: 02 Feb 2012

REFERENCES

  • Choi C. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 2005;5:30.
  • Clarke R, Currier S, Kaplan O, Lovelace E, Boulay V, Gottesman MM, Dickson RB. Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells. J Natl Cancer Inst 1992;84:1506–1512.
  • Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. Overexpression of a transporter gene in a multidrug-resistant human lung AM cancer cell line. Science 1992;258:1650–1654.
  • Coley HM. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev 2008;34:378–390.
  • Cox DS, Scott KR, Gao H, Raje S, Eddington ND. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants. J Pharm Sci 2001;90:1540–1552.
  • Damle BD, Sridhar R, Desai PB. Dipyridamole modulates multidrug resistance and intracellular as well as nuclear levels of doxorubicin in B16 melanoma cells. Int J Cancer 1994;56:113–118.
  • Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001;42:1007–1017.
  • Fojo T, Coley HM. The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategies. Clin Breast Cancer 2007;7:749–756.
  • Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48–58.
  • Gottesman MM, Ling V. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 2006;580:998–1009.
  • Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U. Functional polymorphisms of the human multiresistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473–3478.
  • Kamel AM, El-Sharkawy N, Yassin D, Shaaban K, Hussein H, Sidhom I, Abo El-Naga S, Ameen M, El-Hattab O, Aly El-Din NH. P-gp expression and Rh 123 efflux assay have no impact on survival in Egyptian pediatric acute lymphoblastic leukemia patients. J Egypt Natl Canc Inst 2005;17:165–172.
  • Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Breast Cancer Res 2001;3:253–263.
  • Loetchutinat C, Saengkhae C, Marbeuf-Gueye C, Garnier-Suillerot A. New insights into the P-glycoprotein-mediated effluxes of rhodamines. Eur J Biochem 2003;270:476–485.
  • Ludwig JA, Szakács G, Martin SE, Chu BF, Cardarelli C, Sauna ZE, Caplen NJ, Fales HM, Ambudkar SV, Weinstein JN, Gottesman MM. Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res 2006;66:4808–4815.
  • Nobili S, Landini I, Giglioni B, Mini E. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 2006;7:861–879.
  • Pauli-Magnus C, Feiner J, Brett C, Lin E, Kroetz DL. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects. Clin Pharmacol Ther 2003;74:487–498.
  • Weaver JL, Pine PS, Aszalos A, Schoenlein PV, Currier SJ, Padmanabhan R, Gottesman MM Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells. Exp Cell Res. 1991;196:323–329.
  • Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996;97:2517–2524.
  • Skarke C, Jarrar M, Schmidt H, Kauert G, Langer M, Geisslinger G, Lötsch J. Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers. Pharmacogenetics 2003;13:651–660.
  • Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. J Pharm Pharm Sci 2007;10:350–357.
  • Wandel C, Kim R, Wood M, Wood A. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology 2002; 96:913–920.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.